Home › Prostaatkanker › South Carolina › Charleston
Prostaatkanker klinische studies in Charleston, SC
15 studies voor Prostaatkanker zoeken deelnemers op locaties in en rond Charleston (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
RekruterenFase 2
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruterenFase 2
- Medical University of South Carolina, Charleston
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekruterenFase 3
- Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RekruterenFase 3
- MUSC Hollings Cancer Center, Charleston
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
RekruterenFase 2
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
RekruterenFase 1
- Medical University of South Carolina - Hollings Cancer Center, Charleston
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RekruterenFase 3
- Medical University of South Carolina, Charleston
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
RekruterenFase 1
- Medical University of South Carolina, Charleston
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekruterenFase 3
- Medical University of South Carolina, Charleston
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RekruterenObservatieonderzoek
- Ralph H. Johnson VA Medical Center, Charleston
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
RekruterenFase 2
- Hollings Cancer Center at Medical University of South Carolina, Charleston
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
RekruterenFase 2
- Medical University of South Carolina Hollings Cancer Center, Charleston
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Medical University of South Carolina, Charleston
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- Research Site 123, Charleston
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RekruterenFase 3
- Medical University of South Carolina, Charleston
Prostaatkanker studies in andere steden
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN43 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Andere studies in Charleston
- Depressie19 studies
- Beroerte18 studies
- Hartfalen18 studies
- Niet-kleincellige longkanker16 studies
- Posttraumatische stressstoornis16 studies
- Cardiovasculaire ziekte15 studies
- Kanker (alle vormen)14 studies
- Plaveiselcelcarcinoom van hoofd en hals14 studies
- Ziekte van Parkinson13 studies
- Interstitiële longziekten13 studies
- Borstkanker12 studies
- Longkanker11 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.